Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/11/2007 | US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
01/11/2007 | US20070010531 Substituted pyrazole compounds |
01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
01/11/2007 | US20070010509 Cycloamine ccr5 receptor antagonists |
01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
01/11/2007 | US20070010452 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
01/11/2007 | US20070009980 Continuous fluorogenic analyte assays with dendritic amplification of signal |
01/11/2007 | CA2614116A1 Histamine h3 receptor antagonists |
01/11/2007 | CA2613435A1 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
01/11/2007 | CA2613045A1 Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
01/10/2007 | EP1741715A1 Epothilone derivatives and their synthesis and use |
01/10/2007 | EP1741710A1 Pyrrolidine derivative |
01/10/2007 | EP1741703A1 Pyridone derivative |
01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
01/10/2007 | EP1740580A2 Crystalline 2-amino-3-cyanoquinoline derivatives , process of their preparation and pharmaceutical compositions containing them |
01/10/2007 | EP1740578A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases |
01/10/2007 | EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
01/10/2007 | EP1740574A2 4-amino-5-cyanopyrimidine derivatives |
01/10/2007 | EP1740572A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds |
01/10/2007 | EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives |
01/10/2007 | EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
01/10/2007 | EP1740549A2 Novel imidazoles |
01/10/2007 | EP1740548A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes |
01/10/2007 | EP1740185A1 Benzodiazepines for treating or preventing rsv infection |
01/10/2007 | EP1740100A1 Xanthene dyes |
01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
01/10/2007 | CN1894236A Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
01/10/2007 | CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
01/10/2007 | CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof |
01/09/2007 | US7161012 Processes for preparing amorphous atorvastatin hemi-calcium |
01/09/2007 | US7160999 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
01/09/2007 | US7160955 Polymers with oxygen stability, heat resistance, radiation resistance and ozone resistance for polymers such as polybutadiene modified with sulfur or sulfoxide groups |
01/09/2007 | US7160916 Method of increasing bone density or treating osteoporosis |
01/09/2007 | US7160915 N-methyl-substituted benzamidazoles |
01/09/2007 | US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
01/09/2007 | US7160891 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
01/09/2007 | US7160887 Aromatic amine derivatives, their production and use |
01/09/2007 | US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
01/09/2007 | US7160877 Aliphatic nitrogen-containing 5-membered ring compound |
01/09/2007 | US7160870 Thrombopoietin mimetics |
01/09/2007 | US7160535 Cardiovascular disorders; antiischemic agents; complex of antioxidant and organometallic compound |
01/09/2007 | CA2375372C Mutual prodrugs of amlodipine and atorvastatin |
01/09/2007 | CA2294033C Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
01/04/2007 | WO2007002584A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
01/04/2007 | WO2007002057A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
01/04/2007 | WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists |
01/04/2007 | WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
01/04/2007 | WO2007000334A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
01/04/2007 | WO2007000240A1 Isoquinoline derivatives as inhibitors of rho-kinase |
01/04/2007 | WO2006100481A3 Preparations of 11c methyl iodide and of the radioligand 11c gb67 |
01/04/2007 | WO2006047479A3 C-fms kinase inhibitors |
01/04/2007 | WO2006041872A3 Thrombin receptor antagonists |
01/04/2007 | WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors |
01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
01/04/2007 | US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents |
01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
01/04/2007 | US20070004758 [2-Alkyl-3-(phenylaminocarbonyl)-4-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-5-(p-fluorophenyl)pyrrol-1-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; P38 map kinase inhibitors |
01/04/2007 | US20070004729 Methods and compositions of novel triazine compounds |
01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
01/04/2007 | CA2611971A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
01/04/2007 | CA2611295A1 Isoquinoline derivatives as inhibitors of rho-kinase |
01/04/2007 | CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists |
01/04/2007 | CA2609957A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
01/03/2007 | EP1737925A1 New organic luminescent element |
01/03/2007 | EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
01/03/2007 | EP1737852A2 Polycyclic pyridines as potassium ion channel modulators |
01/03/2007 | EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides |
01/03/2007 | EP1737841A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
01/03/2007 | EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
01/03/2007 | EP1737839A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds |
01/03/2007 | EP1737838A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
01/03/2007 | EP1737830A1 Tri-substituted ureas as cytokine inhibitors |
01/03/2007 | EP1737822A1 N-'4-4(4-morpholinyl) phenyl!-'(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors |
01/03/2007 | EP1737463A1 Pyrimidines with tie2 (tek) activity |
01/03/2007 | EP1737462A1 Pyrimidines with tie2 (tek) activity |
01/03/2007 | EP1737414A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain |
01/03/2007 | EP1572685B1 Substituted benzodioxepins |
01/03/2007 | EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
01/03/2007 | CN1890235A Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
01/03/2007 | CN1890234A Novel quinoline derivatives |
01/03/2007 | CN1890217A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B |
01/03/2007 | CN1890208A Opioid receptor antagonists |
01/03/2007 | CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
01/03/2007 | CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
01/03/2007 | CN1293075C Indole and 2,3-indoline derivative, their preparation and application |
01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
01/03/2007 | CN1293061C Novel branched substituted amino derivatives of 3-amino-1-phemyl-1H-[1,2,4]triazo, methods for producing them and pharmaceutica compositions containing them |
01/03/2007 | CN1293059C New Carboxglic acid derivative, its preparation and application |